Qserve is happy to announce that as of the 1st of July we have opened an office in the UK. The new location is a great addition to our growing global footprint. With rapid business growth and the addition of Sue Spencer (see press release), it is a logical step to start a legal entity and office in one of the main medical device markets in the EU.
The future foresees that we must deal with a Brexit. For manufacturers globally who place their products on the UK market, it will most likely mean they have to be compliant with UK legislation on medical devices and IVD as well as having a UK authorized representative. On the other side, the UK manufacturers will have to comply or continue to comply (depending on the timing) with the MDR and IVDR applicable for the EU market.
Jan van Lochem, CEO of Qserve, lists the advantages of a UK presence: “First of all, the UK is one of the key medical device markets in the EU. The addition of an office and local team is to support our customers in the increasingly challenging regulatory environment while building Qserve’s presence as the leading regulatory, quality and clinical partner for the MedTech industry. Secondly, with the upcoming Brexit we can support all our customers with registrations in the UK. And finally, the UK always has been a frontrunner on regulatory knowledge resulting in a strong community of RA/QA experts, some of which may be interested to join our global team.”
The registered business address of Qserve Group UK, Ltd is 49 Greek Street, London, W1D 4EG, United Kingdom. To contact our local team, please email Sue Spencer at firstname.lastname@example.org. For more information and to view Qserve’s other locations please visit: www.qservegroup.com .